Latest News and Press Releases

 FDA accepts Dupixent® (dupilumab) for priority review in adults with prurigo nodularis Dupixent would be the first and only medicine specifically indicated to treat prurigo nodularis in the U.S.,...

        Positive scientific opinion under Early Access to Medicines Scheme (EAMS) will make efgartigimod available to eligible generalized myasthenia gravis (gMG) patients in the UK prior to marketing...

Approval based on interim RAINBOWFISH data which show pre-symptomatic babies treated with Evrysdi for at least one year were able to sit, stand and walk Prescribing information updated with FIREFISH...

REGULATED INFORMATION Mont-Saint-Guibert, Belgium, 31 May 2022, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in...

BRAMPTON, Ontario, May 31, 2022 (GLOBE NEWSWIRE) -- Canada’s Hero Award-winning anti-poverty organization Help A Girl Out (HAGO) is having its first fundraising and awards gala & dinner at the...

Pune, May 31, 2022 (GLOBE NEWSWIRE) -- Global “Collaborative Software Market” report explores Comprehensive and Insightful Information about various key factors like Regional Growth, Segmentation,...

Pune, May 31, 2022 (GLOBE NEWSWIRE) -- Global “Beer Shampoo Market” Research Report [2022-2027] features an intrinsic analysis of current growth status and provides detailed insights into market...

Washington, D.C., May 31, 2022 (GLOBE NEWSWIRE) -- A new collaboration aims to boost equitable access to vital fisheries intelligence, data analysis and capacity building assistance to help...

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) -- One barely ever sees someone from the field of science doing any creative work. This is because many perceive the two skills to be poles apart. But trends...

NEW ORLEANS, May 30, 2022 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...